A new study provides the first empirical evidence that the not-for-profit manufacturer’s business model can lead to robust drug supplies and lower medicine costs.
Tag Archive for: pharmaceutical manufacturing
Upcoming regulatory changes surrounding the use of perfluoroalkyl and polyfluoroalkyl substances (PFAS) have been making headlines across the globe. As the United States and European Union continue to move toward banning and limiting the use of PFAS products, the pharmaceutical industry, much like others, must address the mounting risks related to this family of chemicals.
The scholarships will prioritize students from underrepresented groups, who have overcome disadvantages or are first generation to attend college. The research collaboration aims to develop new methods for delivering therapies to patients.
